Integrating Good Manufacturing Practices During the Transition from Clinical Trials To Commercial Manufacturing
white paper
Description:
Our experience shows that early adoption of GMP (Good Manufacturing Practices) by a company, can lead to a faster, lower-cost ramp-up from clinical trials to full commercial manufacturing, in-house or out-sourced. The interpretation of compliance regulations, and subsequent recommendations in this document, are a compilation of years of experience and best practices from leading bio/pharmaceutical companies.
Please complete the registration form below for this white paper.
